Previous close | 0.0002 |
Open | 0.0002 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.0002 - 0.0002 |
52-week range | 0.0001 - 0.0155 |
Volume | |
Avg. volume | 24,186 |
Market cap | 29,019 |
Beta (5Y monthly) | 81.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides an update to shareholders.